한쪽 엽에 국한된 고분화 갑상선암에서 갑상선 엽절제술의 의의
Thyroid Lobectomy for Treatment of Well Differentiated Thyroid Cancer Confined to One Lobe
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There has been controversy of the lobectomy for well differentiated thyroid cancer (WDTC). Current guidelines recommend total thyroidectomy for the cancer over 1cm, despite previous report suggesting that the lobectomy provides similar excellent outcomes. The purpose of our study is to report our experience of WDTC treated by thyroid lobectomy. Methods: We retrospectively analyzed 284 patients with WDTC treated by thyroid lobectomy at department of Surgery in Chosun University Hospital from January 2002 to December 2010. Overall survival (OS) and disease-free survival (DFS) were determined by the Kaplan-Meier method. Factors predictive of recurrence by univariate and multivariate analysis were determined using the χ2 test and Cox proportional hazard model respectively. Results: With a mean follow-up of 60.4 months, OS and RFS for all patients were 97.9% and 96.5% respectively. No patient died due to WDTC. Univariate analysis showed statistically significant differences in recurrence by tumor size (P=0.013) and presence of invasion (P=0.039). However, Multivariate analysis showed no significant difference in local recurrence. Conclusion: Patients with WDTC confined to one lobe can be safely treated by lobectomy.
Abstract
Purpose: There has been controversy of the lobectomy for well differentiated thyroid cancer (WDTC). Current guidelines recommend total thyroidectomy for the cancer over 1cm, despite previous report suggesting that the lobectomy provides similar excellent outcomes. The purpose of our study is to report our experience of WDTC treated by thyroid lobectomy. Methods: We retrospectively analyzed 284 patients with WDTC treated by thyroid lobectomy at department of Surgery in Chosun University Hospital from January 2002 to December 2010. Overall survival (OS) and disease-free survival (DFS) were determined by the Kaplan-Meier method. Factors predictive of recurrence by univariate and multivariate analysis were determined using the χ2 test and Cox proportional hazard model respectively. Results: With a mean follow-up of 60.4 months, OS and RFS for all patients were 97.9% and 96.5% respectively. No patient died due to WDTC. Univariate analysis showed statistically significant differences in recurrence by tumor size (P=0.013) and presence of invasion (P=0.039). However, Multivariate analysis showed no significant difference in local recurrence. Conclusion: Patients with WDTC confined to one lobe can be safely treated by lobectomy.
참고문헌 (18)
- Chen AY, "Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005", Cancer, 115, pp.3801~3807 (2009)
- Enewold L, "Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005", Cancer Epidemiol Biomarkers Prev, 18, pp.784~791 (2009)
- Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295, pp.2164~2167 (2006)
- Shah JP, "Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis", Am J Surg, 166, pp.331~335 (1993)
- Hay ID, "Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system", Surgery, 102, pp.1088~1095 (1987)
- Sanders LE, "Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment", Arch Surg, 133, pp.419~425 (1998)
- Loh KC, "Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients", J Clin Endocrinol Metab, 82, pp.3553~3562 (1997)
- Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer", Am J Med, 97, pp.418~428 (1994)
- 이가희, "대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안", 대한영상의학회지, 64(4), pp.389~416 (2011), 대한영상의학회
- Shaha AR, "Risk group stratification and prognostic factors in papillary carcinoma of thyroid", Ann Surg Oncol, 3, pp.534~538 (1996)
- Sugitani I, "Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country", World J Surg, 34, pp.1265~1273 (2010)
- Cady B, "An expanded view of risk-group definition in differentiated thyroid carcinoma", Surgery, 104, pp.947~953 (1988)
- McConahey WM, "Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome", Mayo Clin Proc, 61, pp.978~996 (1986)
- Hay ID, "Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989", Surgery, 114, pp.1050~1057 (1993)
- Lin HW, "Survival impact of treatment options for papillary microcarcinoma of the thyroid", Laryngoscope, 119, pp.1983~1987 (2009)
- Saadi H, "Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma", Surgery, 130, pp.30~35 (2001)
- Hay ID, "Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients", World J Surg, 26, pp.879~885 (2002)
- 이민재, "유두상 갑상선암에서 최소 갑상선외 침범의 예후인자로서의 유용성", 대한내분비외과학회지, 12(2), pp.102~106 (2012), 대한갑상선-내분비외과학회